Antibodies

Lung cancers are the third most diagnosed cancer in the United States, with about 13.5% of new cancer cases classified as lung, contributing 27.2% of cancer deaths yearly. As of 2011, there were approximately 402,000 people living with lung cancer in the United States. Those diagnosed with lung cancer have a 5 year survival rates of only 16.8%. Over the last 10 years, the rate of new lung cancer cases has fallen 1.5% per year, while the death rate has fallen 1.8% per year. Biocare Medical is proud to offer key lung antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD,https://seer.cancer.gov/statfacts/html/lungb.html

Desmoglein 3 + Napsin A	$717.00Select options
TTF-1 + CK5	$756.00Select options
p63 + TRIM29	$954.00Select options
p40 (M)	$358.00 – $3,434.00Select options
Folate Receptor alpha IHC Assay Kit	$2,100.00 – $2,314.00Select options
Cytokeratin 7 (CK7)	$250.00 – $903.00Select options
CD56	$313.00 – $1,260.00Select options
Surfactant apoprotein-A [32E12]	$200.00 – $1,187.00Read more
Calretinin	$282.00 – $1,212.00Select options

Pancreatic cancers are a rare diagnosed cancer in the United States, with about 2.8% of new cancer cases classified as pancreatic, contributing approx.. 6.8% of cancer deaths yearly. As of 2011, there were approximately 44,000 people living with pancreatic cancer in the United States. Those diagnosed with pancreatic cancer have a 5 year survival rate of 6.7%. Over the last 10 years, the rate of new cancer cases has been stable while the death rate has risen 0.4% each year. Biocare Medical is proud to offer key pancreatic and gall bladder antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Pancreas Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/pancreas.html

β-catenin	$172.00 – $608.00Select options
CD10	$266.00 – $1,587.00Select options
Chromogranin A	$250.00 – $954.00Select options
Cytokeratin 7	$250.00 – $954.00Select options
Cytokeratin 19	$234.00 – $886.00Select options
E-cadherin	$220.00 – $1,041.00Select options
Glypican 3	$329.00 – $994.00Select options
Mucin 5AC	$295.00Select options
S100P	$313.00 – $965.00Select options

Breast cancers are the second most diagnosed cancer in the United States, with about 14% of new cancer cases classified as breast and contributing 6.9% of cancer deaths yearly. As of 2011, there were approximately 2,900,000 women living with breast cancer in the United States. Those diagnosed with breast cancer have a 5 year survival rate of 89.2%. Over the last 10 years, the new breast cancer case rate has been stable, while the death rate has dropped 1.9% per year. Biocare Medical is proud to offer key breast antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Breast Cancer. National Cancer Institute. Bethesda, MD,http://seer.cancer.gov/statfacts/html/breast.html

CK5/14 + p63 + CK7/18	$1,081.00 – $4,100.00Select options
GCDFP-15 + Mammaglobin	$726.00Select options
p120 + E-cadherin	$802.00Select options
Estrogen Receptor (ER) [SP1]	$343.00 – $3,733.00Select options
Progesterone Receptor (PR) [16]	$358.00 – $1,212.00Select options
GATA-3	$266.00 – $1,118.00Select options
Cytokeratin 7 (CK7)	$250.00 – $903.00Select options
Calponin	$266.00 – $1,151.00Select options
c-erbB-2/HER2	$295.00 – $2,282.00Select options

Cervical cancers are a relatively rare diagnosed cancer in the United States, with about 0.7% of new cancer cases classified as cervical, contributingapprox. 0.7% of cancer deaths yearly. As of 2011, there were approximately 250,000 women living with cervical cancer in the United States. Those diagnosed with cervical cancer have a 5 year survival rate of 67.9%. Over the last 10 years, both the new cancer case rate and the death rate have dropped 1.2% and 1.3% per year, respectively. Biocare Medical is proud to offer key cervical antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Cervix Uteri Cancer. National Cancer Institute. Bethesda, MD,https://seer.cancer.gov/statfacts/html/cervix.html

HPV-16 (CAMVIR-1)	$994.00Select options
HPV Cocktail Broad Spectrum	$605.00 – $1,785.00Select options
CA 125	$231.00 – $971.00Read more
CEA (M)	$204.00 – $684.00Select options
CEA (P)	$102.00 – $319.00Read more
p63	$420.00 – $3,143.00Select options
CD117/c-kit	$329.00 – $903.00Select options
Topoisomerase II alpha	$234.00 – $576.00Select options
VEGF	$622.00 – $1,848.00Select options

Head and neck cancers are rare diagnosed cancers in the United States, with about 2.5% of all new cancer cases classified as oral cavity and pharynx, contributingapprox. 1.4% of cancer deaths yearly. As of 2011, there were approximately 282,000 people living with head and neck cancers in the United States. Those diagnosed with head and neck cancers have a 5 year survival rate of 62.7%. Over the last 10 years, both the new cancer case rate and the death rate have been stable. Biocare Medical is proud to offer key pancreatic and gall bladder antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Oral Cavity and Pharynx Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/oralcav.html

Androgen Receptor	$300.00 – $907.00Select options
Calponin	$266.00 – $1,151.00Select options
CD117/c-kit	$329.00 – $903.00Select options
Cytokeratin 7 (CK7)	$250.00 – $903.00Select options
DOG1	$204.00 – $731.00Select options
GFAP	$172.00 – $731.00Select options
HPV-16	$994.00Select options
p63	$420.00 – $3,143.00Select options
SOX10 (M)	$250.00 – $2,149.00Select options

Ovarian cancers are a relatively rare diagnosed cancer in the United States, with about 1.3% of new cancer cases classified as ovarian yet contributing 2.4% of cancer deaths yearly. As of 2011, there were approximately 189,000 women living with ovarian cancer in the United States. Those diagnosed with ovarian cancer have a 5 year survival rate of 44.6%. Over the last 10 years, both the new cancer case rate and the death rate have dropped 1.1% and 2.0% per year, respectively. Biocare Medical is proud to offer key ovarian antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Ovary Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/ovary.html

PAX8	$234.00 – $1,134.00Select options
CDH17	$266.00 – $795.00Select options
CDX2 + CK7	$922.00 – $3,238.00Select options
CD99	$234.00 – $554.00Select options
CD99	$231.00 – $971.00Read more
CK7	$250.00 – $903.00Select options
CDX2	$406.00 – $2,387.00Select options
Human Chorionic Gonadotropin (Beta)	$158.00 – $349.00Select options
Inhibin, Alpha	$295.00 – $1,260.00Select options